HIGHLIGHTS
- who: Thaninee, Prasoppokakorn and Kessarin, Thanapirom from the Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand have published the research: Case Report Nephrotic Syndrome Induced by Lenvatinib Treatment for Hepatocellular Carcinoma, in the Journal: Case Reports in Hepatology of 14/02/2022
- what: The authors report herein the case of lenvatinib-induced NS in a cirrhotic patient with HCC with resolution of symptoms in a short period after drug discontinuation.
SUMMARY
Lenvatinib is an oral small-molecule multiple tyrosine kinase inhibitor (TKI) that inhibits vascular endothelial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.